CoreAge Rx / Spot On
HYDROQUINONE · KOJIC ACID · NIACINAMIDE
Spot On is CoreAge’s hydroquinone-containing pigmentation offer. The current page starts at $54.99/month and names hydroquinone, kojic acid and niacinamide; the diagnosis and prescribed strengths matter.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 0% OF THE MODEL. 6 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Read the complete order, prescription and renewal terms before starting.
The verdict
A dark spot is a description, not a diagnosis. Before comparing this cream with another pigment treatment, establish what is being treated and whether a lesion needs direct examination. A bleaching-product page cannot make that distinction for the reader.
CoreAge names three active ingredients but does not quantify them in the accessible current panel. We do not infer concentrations from another brand or from older promotional copy. Ask for the actual prescribed preparation.
- The current product page names its intended use and headline ingredients.
- The order requires clinical review before a prescription is dispensed.
- Public marketing does not establish patient-specific suitability or finished-product results.
- Ask for the full ingredient list, exact quantity and any details not shown in the offer.
Every active, assessed
- HydroquinoneCONFIRM PRESCRIBED STRENGTH
Pigmentation-directed ingredient
- BENCHMARK
- Confirm the actual dispensed formula and instructions
- ASSESSMENT
- Needs an appropriate diagnosis, clinician instructions and a reassessment plan.
- Kojic acid / niacinamideCONFIRM PRESCRIBED STRENGTHS
Other ingredients named by CoreAge
- BENCHMARK
- Confirm the actual dispensed formula and instructions
- ASSESSMENT
- A shared ingredient name does not establish equivalence to a different pigmentation formula.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| HydroquinonePigmentation-directed ingredient | CONFIRM PRESCRIBED STRENGTH | Confirm the actual dispensed formula and instructions | Needs an appropriate diagnosis, clinician instructions and a reassessment plan. |
| Kojic acid / niacinamideOther ingredients named by CoreAge | CONFIRM PRESCRIBED STRENGTHS | Confirm the actual dispensed formula and instructions | A shared ingredient name does not establish equivalence to a different pigmentation formula. |
Scoring
- FINISHED-PRODUCT EVIDENCEWEIGHT 30%NOT ASSESSED
Ingredient background is not a controlled trial of this finished preparation.
- FORMULATION INTEGRITYWEIGHT 20%NOT ASSESSED
We have not independently tested stability, delivery or batch quality.
- DISCLOSUREWEIGHT 15%NOT ASSESSED
Published details and open questions are recorded without a numerical product score.
- TOLERANCEWEIGHT 15%NOT ASSESSED
No patient panel or clinical safety audit was conducted.
- TEXTUREWEIGHT 10%NOT ASSESSED
We did not apply or sensory-test the product.
- COST PER APPLICATIONWEIGHT 10%NOT ASSESSED
The actual prescribed amount and supply period must be established before comparison.
Open the review comparison tray →
The diagnosis comes before the comparison
Melasma, post-inflammatory marks and a changing pigmented lesion have different implications. AAD discusses hydroquinone and other prescription options for melasma alongside sun protection. That background does not make every dark area a candidate for this cream.
Tell the clinician when the mark appeared, whether it is changing and what treatments have already been used. Ask whether photographs are adequate for the concern or whether an in-person examination is needed. Avoid using a cosmetic category as reassurance about an undiagnosed lesion.
Do not read strength as a promise of speed
A larger percentage is not enough to establish a better treatment. Formulation, diagnosis, application area, tolerance and the treatment plan all matter. The current product panel does not publish the strengths needed to make even a simple ingredient-by-ingredient comparison.
FDA has received reports of adverse effects with hydroquinone skin-lightening products, including irritation and ochronosis. That warning is context for a careful clinical discussion, not proof that this particular preparation caused those events. Ask what monitoring and stopping instructions apply to the prescribed order.
A pigment plan needs a review point
Ask when the clinician wants to reassess the result, what to do if irritation develops and how ongoing sun protection fits the plan. Do not infer that a recurring subscription means uninterrupted use is appropriate indefinitely.
Compare the complete offer with Likeness’s separately listed Dark Spot Cream and with the alternatives your clinician identifies. The current price, exact preparation and follow-up arrangement should be visible together. A featured position cannot answer the medical question.
The order is not the treatment plan
Keep the chosen product, full payment and next renewal date together. A starting monthly price may describe a recurring plan or a monthly equivalent. Confirm the dispensing quantity, shipping, consultation charges and what is owed before repeating an order. A delivery estimate does not include every possible delay in clinical review or fulfillment.
CoreAge’s general policy distinguishes stopping a future subscription from refunding an order already approved and transmitted to a pharmacy. It describes possible non-refundable consultation fees and a separate 30-day cutoff. Read the terms attached to the selected skincare order and resolve any different checkout promise before paying.
How this record was prepared
We read public product and policy pages on October 5, 2026 and checked the ingredient context against the sources below. We did not order the cream, inspect a pharmacy batch, interview a treating clinician or test it on a patient panel. Product directions can change; the label and clinician’s instructions for the dispensed prescription take priority over a general review.
This is a public-source assessment. Unmeasured clinical results, texture and tolerance are not converted into a product score. Our featured-provider order is a separate publisher preference, described in the disclosure. It is not a clinical ranking of these formulas.
Who this is for
- You want to discuss this particular formula with a clinician.
- You can compare the full payment and follow-up arrangement before ordering.
- You have not resolved relevant allergies, pregnancy plans or medical-history questions with the clinician.
- You need an assessment of a new, changing or undiagnosed skin lesion.
Read the complete order, prescription and renewal terms before starting.
This is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01CoreAge Rx — Spot On Public source checked October 5, 2026. Provider descriptions are not independent product testing.
- S-02AAD — melasma diagnosis and treatment Medical or regulatory context checked October 5, 2026; not a study of the reviewed finished product.
- S-03FDA — hydroquinone skin-lightening product safety Regulatory status and reported adverse effects; this is not a trial of Spot On or Likeness. Checked October 5, 2026.
- S-04CoreAge Rx — payment, subscription and refund policy Public source checked October 5, 2026. Provider descriptions are not independent product testing.
- S-05FDA — compounding questions and answers Medical or regulatory context checked October 5, 2026; not a study of the reviewed finished product.